AC Immune SA
ACIU- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001651625
No open-market purchases or sales by AC Immune SA insiders were filed in the last 90 days; 43 institutions reported holding it in 13F filings for Q2 2026, worth $58.2M in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in AC Immune SA as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 36
- −7 vs. Q4 2021
- Shares held
- 14.3M
- −711.6K (−4.7%) vs. Q4 2021
- Total value
- $57.2M
- −$17.1M (−23.0%) vs. Q4 2021
- New holders
- 3
- 10 more added
- Sold out
- 10
- 13 more reduced
1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ACIU on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 43 | $58.2M |
| Q1 2026 | 47 | $69.2M |
| Q4 2025 | 42 | $81.2M |
| Q3 2025 | 40 | $71.1M |
| Q2 2025 | 42 | $49.7M |
| Q1 2025 | 41 | $48.5M |
| Q4 2024 | 45 | $73.9M |
| Q3 2024 | 43 | $106.6M |
| Q2 2024 | 45 | $114.0M |
| Q1 2024 | 37 | $85.7M |
| Q4 2023 | 32 | $148.2M |
| Q3 2023 | 28 | $45.5M |
| Q2 2023 | 31 | $47.4M |
| Q1 2023 | 34 | $33.0M |
| Q4 2022 | 37 | $30.1M |
| Q3 2022 | 34 | $44.3M |
| Q2 2022 | 35 | $49.8M |
| Q1 2022 | 36 | $57.2M |
| Q4 2021 | 44 | $74.5M |
| Q3 2021 | 64 | $118.5M |
| Q2 2021 | 57 | $144.3M |
| Q1 2021 | 51 | $138.5M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding AC Immune SA; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BVF Inc | 7,428,379 | $29.7M | 1.19% | +366,000+5.2% | Added |
| Morgan Stanley | 2,004,472 | $8.02M | 0.00% | −238,992−10.7% | Reduced |
| Platinum Investment Management Ltd | 1,062,462 | $4.25M | 0.13% | 00.0% | Unchanged |
| Artal Group S.A. | 1,000,000 | $4.00M | 0.17% | 00.0% | Unchanged |
| Wells Fargo & Company | 491,356 | $1.97M | 0.00% | +77,276+18.7% | Added |
| EcoR1 Capital, LLC | 485,005 | $1.94M | 0.06% | −264,580−35.3% | Reduced |
| Renaissance Technologies LLC | 452,490 | $1.81M | 0.00% | +10,300+2.3% | Added |
| BlackRock Inc. | 292,273 | $1.17M | 0.00% | +4,685+1.6% | Added |
| Deutsche Bank AG | 284,043 | $1.14M | 0.00% | +24,568+9.5% | Added |
| Assenagon Asset Management S.A. | 147,435 | $590.0K | 0.00% | 00.0% | Unchanged |
| Eversept Partners, LP | 124,589 | $498.4K | 0.05% | −28,791−18.8% | Reduced |
| Handelsbanken Fonder AB | 101,064 | $404.0K | 0.00% | +101,064 | New |
| State Street Corp | 58,768 | $235.0K | 0.00% | +2,530+4.5% | Added |
| Alpine Woods Capital Investors, LLC | 50,000 | $200.0K | 0.02% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 37,118 | $148.0K | 0.00% | 00.0% | Unchanged |
| Virtus ETF Advisers LLC | 31,014 | $124.0K | 0.06% | −1,838−5.6% | Reduced |
| Goldman Sachs Group Inc | 28,807 | $115.0K | 0.00% | +2,184+8.2% | Added |
| Susquehanna International Group, LLP | 26,108 | $104.0K | 0.00% | −56,399−68.4% | Reduced |
| Susquehanna Fundamental Investments, LLC | 24,717 | $99.0K | 0.00% | −1,800−6.8% | Reduced |
| Two Sigma Advisers, LP | 23,644 | $95.0K | 0.00% | −70,200−74.8% | Reduced |
| Banque Cantonale Vaudoise | 21,617 | $86.0K | 0.00% | −29,404−57.6% | Reduced |
| Kingsbury Capital Investment Advisors LLC | 18,975 | $76.0K | 0.08% | +18,975 | New |
| UBS Group AG | 18,825 | $75.0K | 0.00% | −73,669−79.6% | Reduced |
| Cohen Lawrence B | 12,850 | $51.0K | 0.03% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 12,707 | $51.0K | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 10,520 | $42.0K | 0.00% | +10,520 | New |
| Compagnie Lombard Odier SCmA | 10,000 | $40.0K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 9,430 | $38.0K | 0.00% | +2,398+34.1% | Added |
| Tower Research Capital LLC (TRC) | 7,657 | $30.0K | 0.00% | +2,166+39.4% | Added |
| Royal Bank of Canada | 6,800 | $27.0K | 0.00% | −5,859−46.3% | Reduced |
| Bank of America Corp | 3,754 | $15.0K | 0.00% | +1,019+37.3% | Added |
| Advisor Group Holdings, Inc. | 3,100 | $12.0K | 0.00% | −1,100−26.2% | Reduced |
| Citigroup Inc | 1,700 | $7.00K | 0.00% | −707−29.4% | Reduced |
| Daiwa Securities Group Inc. | 158 | $1.00K | 0.00% | 00.0% | Unchanged |
| Strengthening Families & Communities, LLC | 200 | $1.00K | 0.00% | 00.0% | Unchanged |
| FMR LLC | 51 | $0 | 0.00% | −1−1.9% | Reduced |
| Lombard Odier Asset Management (Switzerland) SA | 0 | $0 | 0.00% | −348,196−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −73,046−100.0% | Sold out |
| Pura Vida Investments, LLC | 0 | $0 | 0.00% | −33,997−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −32,400−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −25,613−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −15,327−100.0% | Sold out |
| ProShare Advisors LLC | 0 | $0 | 0.00% | −11,230−100.0% | Sold out |
| Saturna Capital CORP | 0 | $0 | 0.00% | −11,100−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −8,855−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −2,188−100.0% | Sold out |
| Metatron Capital SICAV plc | – | – | – | – | Not filed |